ID

9963

Description

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Keywords

  1. 3/8/15 3/8/15 -
  2. 3/9/15 3/9/15 -
  3. 4/24/15 4/24/15 -
  4. 7/9/15 7/9/15 - Martin Dugas
  5. 4/13/21 4/13/21 - Ahmed Rafee, MD
  6. 11/17/21 11/17/21 -
Uploaded on

March 9, 2015

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Follow-up
Description

Follow-up

Consecutive Follow-up Number
Description

Follow up number

Data type

integer

Alias
UMLS CUI-1
C1704685
Concomitant Disease
Description

Concomitant Disease

Alias
UMLS CUI-1
C0243087
Number
Description

Number

Data type

integer

Alias
UMLS CUI-1
C0243087
UMLS CUI-2
C0237753
Date of Diagnosis
Description

Date of Diagnosis

Data type

date

Alias
UMLS CUI-1
C0243087
Diagnosis
Description

Diagnosis

Data type

text

Alias
UMLS CUI-1
C0243087
Therapy
Description

Therapy

Number
Description

Number

Data type

integer

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0237753
Therapy after end of study
Description

Therapy after end of study

Data type

integer

Alias
UMLS CUI-1
C0814259
Description of Therapy
Description

Description of Therapy

Data type

text

Alias
UMLS CUI-1
C0087111
Start Date of Therapy
Description

Start Date of Therapy

Data type

date

Alias
UMLS CUI-1
C0087111
Reason for Therapy
Description

Reason for Therapy

Data type

integer

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0392360
Response before Therapy
Description

Response before Therapy

Data type

integer

Alias
UMLS CUI-1
C0871261
Response after Therapy
Description

Response after Therapy

Data type

integer

Alias
UMLS CUI-1
C0871261
Date of evaluation after therapy
Description

Date of evaluation after therapy

Data type

date

Alias
UMLS CUI-1
C1261322
Allogenic Transplantation
Description

Allogenic Transplantation

Alias
UMLS CUI-1
C0149615
Date of Transplantation
Description

Date of Transplantation

Data type

date

Alias
UMLS CUI-1
C0149615
Transplant
Description

Transplant

Data type

integer

Alias
UMLS CUI-1
C0149615
HLA-Constellation
Description

HLA-Constellation

Data type

integer

Alias
UMLS CUI-1
C0019627
Donor
Description

Donor

Data type

integer

Alias
UMLS CUI-1
C0013018
Donor Comment
Description

Donor Comment

Data type

text

Conditioning before transplant
Description

Conditioning before transplant

Data type

text

Alias
UMLS CUI-1
C0376450
EBMT Identifier
Description

EBMT Identifier

Data type

text

Alias
UMLS CUI-1
C0600091
Signature
Description

Signature

Date
Description

Date

Data type

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Description

Name of Investigator

Data type

text

Alias
UMLS CUI-1
C0008961
Signature of investigator
Description

Signature of investigator

Data type

text

Alias
UMLS CUI-1
C2346576

Similar models

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Follow-up
Follow up number
Item
Consecutive Follow-up Number
integer
C1704685 (UMLS CUI-1)
Item Group
Concomitant Disease
C0243087 (UMLS CUI-1)
Number
Item
Number
integer
C0243087 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Date of Diagnosis
Item
Date of Diagnosis
date
C0243087 (UMLS CUI-1)
Diagnosis
Item
Diagnosis
text
C0243087 (UMLS CUI-1)
Item Group
Therapy
Number
Item
Number
integer
C0087111 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Item
Therapy after end of study
integer
C0814259 (UMLS CUI-1)
Code List
Therapy after end of study
CL Item
Chemotherapy (1)
CL Item
Allogenic Transplantation (as mentioned below) (2)
CL Item
other (3)
Description of Therapy
Item
Description of Therapy
text
C0087111 (UMLS CUI-1)
Start Date of Therapy
Item
Start Date of Therapy
date
C0087111 (UMLS CUI-1)
Item
Reason for Therapy
integer
C0087111 (UMLS CUI-1)
C0392360 (UMLS CUI-2)
Code List
Reason for Therapy
CL Item
Reinduction (1)
CL Item
Consolidation (2)
CL Item
Other (3)
Item
Response before Therapy
integer
C0871261 (UMLS CUI-1)
Code List
Response before Therapy
CL Item
CR (1)
CL Item
CRi (2)
CL Item
OR (3)
CL Item
RD (4)
CL Item
Relapse (5)
Item
Response after Therapy
integer
C0871261 (UMLS CUI-1)
Code List
Response after Therapy
CL Item
CR (1)
CL Item
CRi (2)
CL Item
PR (3)
CL Item
RD (4)
CL Item
Relapse (5)
Date of evaluation after therapy
Item
Date of evaluation after therapy
date
C1261322 (UMLS CUI-1)
Item Group
Allogenic Transplantation
C0149615 (UMLS CUI-1)
Date of Transplantation
Item
Date of Transplantation
date
C0149615 (UMLS CUI-1)
Item
Transplant
integer
C0149615 (UMLS CUI-1)
Code List
Transplant
CL Item
PBSCT (1)
CL Item
BM (KM) (2)
Item
HLA-Constellation
integer
C0019627 (UMLS CUI-1)
Code List
HLA-Constellation
CL Item
Full match (0)
CL Item
1 Mismatch (1)
CL Item
2 Mismatches (2)
CL Item
haplo (3)
Item
Donor
integer
C0013018 (UMLS CUI-1)
Code List
Donor
CL Item
family donor (1)
CL Item
unrelated donor (2)
Donor Comment
Item
Donor Comment
text
Conditioning before transplant
Item
Conditioning before transplant
text
C0376450 (UMLS CUI-1)
EBMT Identifier
Item
EBMT Identifier
text
C0600091 (UMLS CUI-1)
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial